The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma

K K C Li1, J Goodall, C R Goding

  • 1Department of Biology, HK University of Science & Technology, Kowloon, HK, China.

British Journal of Cancer
|September 11, 2003
PubMed

Insights

Clear cell sarcoma (CCS) cells express the melanocyte-specific microphthalmia-associated transcription factor (Mitf-M). However, the EWS/ATF1 oncogene does not directly activate the Mitf-M promoter in CCS cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Clear cell sarcoma (CCS) is characterized by the EWS/ATF1 oncogene, a fusion of the Ewings Sarcoma oncogene (EWS) and ATF1.
  • The melanocytic nature of CCS suggests a potential role for the microphthalmia-associated transcription factor (Mitf), a key regulator of melanocyte differentiation.

Purpose of the Study:

  • To investigate the expression and regulation of the melanocyte-specific Mitf isoform (Mitf-M) in CCS.
  • To determine if the EWS/ATF1 oncogene activates the Mitf-M promoter in CCS.

Main Methods:

  • Cultured CCS cell lines (Su-ccs-1, DTC1, Kao, MST-1, MST-2, MST-3) were used to analyze Mitf-M mRNA and protein expression.
  • Transient transfection assays were performed in CCS cells, melanocytes, and non-melanocytic cells to assess Mitf-M promoter activity driven by EWS/ATF1.

Main Results:

  • Mitf-M mRNA and protein were detected in multiple cultured CCS cell lines.
  • Contrary to expectations, EWS/ATF1 did not activate the Mitf-M promoter in transient assays across different cell types.

Conclusions:

  • Cultured CCS cell lines expressing Mitf-M serve as a valuable model for studying Mitf-M in CCS and melanocyte differentiation.
  • The findings suggest that Mitf-M promoter activation in CCS may depend on a specific chromosomal context or that EWS/ATF1 does not directly regulate the Mitf-M promoter.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...